Skip to main content
. 2021 Feb 25;13(5):950. doi: 10.3390/cancers13050950

Figure 5.

Figure 5

MMRd endometrioid carcinoma. The tumor shows numerous intra- and peritumoural TILs (A,B ×200 magnification, C ×400 magnification; Hematoxylin and Eosin-H&E) and diffuse immunohistochemical nuclear loss of MLH1 (D ×400 magnification).